Does LEUPROLIDE Cause Product solubility abnormal? 26 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Product solubility abnormal have been filed in association with LEUPROLIDE (Fensolvi). This represents 0.0% of all adverse event reports for LEUPROLIDE.
26
Reports of Product solubility abnormal with LEUPROLIDE
0.0%
of all LEUPROLIDE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product solubility abnormal From LEUPROLIDE?
Of the 26 reports.
Is Product solubility abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEUPROLIDE. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Product solubility abnormal?
BUPRENORPHINE (498)
BUPRENORPHINE\NALOXONE (274)
POLYETHYLENE GLYCOL 3350 (220)
CHOLESTYRAMINE (193)
PATIROMER (107)
LEVOTHYROXINE (100)
SOMATROPIN (98)
EXENATIDE (97)
ESTRADIOL (94)
NITROGLYCERIN (81)
Which LEUPROLIDE Alternatives Have Lower Product solubility abnormal Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM